DocGo (DCGO) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
DocGo Announces Strong Second Quarter 2022 Results
August 8, 2022 4:05 PM EDTQ2 Revenue of $109.5 Million Up 76% Year-Over-Year; Company Raises Full-Year 2022 Guidance
NEW YORK--(BUSINESS WIRE)-- DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced financial and operating results for the second quarter ending June 30, 2022.
Second Quarter Financial Highlights
Total revenue increased to $109.5 million compared to $62.2 million in Q2 2021, an increase of 76%. Gross margin improved to 35.9% compared to 34.0% in Q2 2021. Net income increased to $11.8 million, compared to $0.1 million in Q2 2021. Adjusted EBITDA1, a non-GAAP measure, increased to $12.3... More